Invention Grant
- Patent Title: Potent anticancer activity via dual compound activation
- Patent Title (中): 通过双重化合物活化,有效的抗癌活性
-
Application No.: US14382546Application Date: 2013-03-04
-
Publication No.: US09592229B2Publication Date: 2017-03-14
- Inventor: Paul J. Hergenrother , Rachel C. Botham , Timothy M. Fan , Mark J. Gilbert , Michael K. Handley , Theodore M. Tarasow
- Applicant: The Board of Trustees of the University of Illinois , Vanquish Oncology, Inc.
- Applicant Address: US IL Urbana US IL Champaign
- Assignee: The Board of Trustees of the University of Illinois,Vanquish Oncology, Inc.
- Current Assignee: The Board of Trustees of the University of Illinois,Vanquish Oncology, Inc.
- Current Assignee Address: US IL Urbana US IL Champaign
- Agency: Haukaas Fortius PLLC
- Agent Michael H. Haukaas
- International Application: PCT/US2013/028880 WO 20130304
- International Announcement: WO2013/131089 WO 20130906
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/437 ; A61K47/40 ; A61K9/00 ; A61K9/20 ; A61K9/48

Abstract:
The invention provides compositions and methods for the induction of cell death, for example, cancer cell death. Combinations of compounds and related methods the use are disclosed, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells. The disclosed drug combinations can have lower neurotoxicity effects than other compounds and combinations of compounds.
Public/Granted literature
- US20150099759A1 POTENT ANTICANCER ACTIVITY VIA DUAL COMPOUND ACTIVATION Public/Granted day:2015-04-09
Information query